Sterling Capital Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$334K Buy
39,364
+28,297
+256% +$188K 0.01% 999
2026
Q1
$60.3K Sell
11,067
-7,031
-39% -$39.5K ﹤0.01% 1562
2025
Q4
$127K Buy
18,098
+8,179
+82% +$64K ﹤0.01% 1441
2025
Q3
$76.7K Buy
9,919
+5,943
+149% +$46.4K ﹤0.01% 1620
2025
Q2
$34.6K Buy
3,976
+1,442
+57% +$10.5K ﹤0.01% 1601
2025
Q1
$20.2K Sell
2,534
-2,095
-45% -$21.2K ﹤0.01% 1650
2024
Q4
$42.1K Buy
4,629
+4,101
+777% +$39.6K ﹤0.01% 1663
2024
Q3
$4.85K Buy
+528
New +$4.37K ﹤0.01% 1777
2017
Q3
Sell
-48,477
Closed -$1.68M 972
2017
Q2
$1.68M Hold
48,477
0.02% 428
2017
Q1
$1.21M Sell
48,477
-3,715
-7% -$77.3K 0.01% 517
2016
Q4
$861K Buy
+52,192
New +$886K 0.01% 638

Other funds holding TDOC

Sterling Capital Management's TDOC Position: Q2 2026 in Review

Sterling Capital Management increased its Teladoc Health (TDOC) stake by 256% in Q2 2026, buying an estimated $188K and bringing the position to 39,364 shares worth $334K. The position accounts for 0.01% of the portfolio, ranked #999.

Sterling Capital Management first reported a position in TDOC in Q4 2016 and has held it in 11 quarters since. The position peaked at $1.68M in Q2 2017. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Sterling Capital Management held 39,364 shares of Teladoc Health worth $334K as of Q2 2026.
  • Sterling Capital Management bought 28,297 Teladoc Health shares in Q2 2026, an estimated $188K.
  • Teladoc Health made up 0.01% of Sterling Capital Management's portfolio in Q2 2026, its #999 holding.
  • Sterling Capital Management first reported a position in Teladoc Health in Q4 2016 and has held it in 11 quarters since.
  • Sterling Capital Management's Teladoc Health position peaked at $1.68M in Q2 2017.
  • 347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.